Fig. 6From: Fibroblast growth factor receptor type 4 as a potential therapeutic target in clear cell renal cell carcinomaA498 xenograft mouse model treated with the FGFR4 selective inhibitor BLU9931.. A, Mice at the end of the study, tumour volume, and body weight course. B, Ki-67, CD34, and D2-40 expression in mouse tumours was assessed via immunohistochemistryBack to article page